Area of research
Virology · Infectious Diseases
Research interest
Research focused on Microbicide and Cytotoxic T cell, with related work in Microbicides for sexually transmitted diseases, CD8, Viral replication. Notable publications include 'A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy', 'HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon', and 'Inhibitory Potential of Subpopulations of CD8 + T Cells in HIV-1-Infected Elite Suppressors'.
Synthesis and Antiviral Evaluation of Octadecyloxyethyl Benzyl 9-[(2-Phosphonomethoxy)ethyl]guanine (ODE-Bn-PMEG), a Potent Inhibitor of Transient HPV DNA Amplification
The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development
HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon
HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4 <sup>+</sup> T Cell Depletion in Humanized BLT Mice
A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy
Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+T cells
CD8+T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants
“Set it and Forget it”: Women’s Perceptions and Opinions of Long-Acting Topical Vaginal Gels
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties
Inhibitory Potential of Subpopulations of CD8<sup>+</sup>T Cells in HIV-1-Infected Elite Suppressors
Safety and efficacy of tenofovir/IQP-0528 combination gels – A dual compartment microbicide for HIV-1 prevention
Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection